Manufacturing capabilities and supply chain infrastructure are critical determinants of the RNA based vaccine market's ability to meet global demand and expand into routine immunization programs. The production of RNA vaccines involves a complex multi-step process that begins with DNA template linearization and proceeds through in vitro transcription, enzymatic capping, purification, and lipid...